Cite

HARVARD Citation

    Capeding, M. et al. (2020). Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study. EClinicalMedicine. p. . [Online]. 
  
Back to record